Protagonist Therapeutics Inc Stock Nasdaq
Equities
US74366E1029
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- PTS | - |
Sales 2024 * | 208M 0 | Sales 2025 * | 120M 0 | Capitalization | 1.47B 0 |
---|---|---|---|---|---|
Net income 2024 * | 44M - | Net income 2025 * | -6M - | EV / Sales 2024 * | 5.24 x |
Net cash position 2024 * | 388M 0 | Net cash position 2025 * | 637M 0 | EV / Sales 2025 * | 6.99 x |
P/E ratio 2024 * |
35.1
x | P/E ratio 2025 * |
-31.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.53% |
Latest transcript on Protagonist Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 67 | 08-11-30 |
Asif Ali
DFI | Director of Finance/CFO | 50 | 22-04-17 |
Chief Tech/Sci/R&D Officer | - | 17-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lewis Williams
BRD | Director/Board Member | 74 | 17-06-07 |
Harold Selick
CHM | Chairman | 69 | 09-01-31 |
Daniel Swisher
BRD | Director/Board Member | 61 | 23-10-25 |
1st Jan change | Capi. | |
---|---|---|
+2.17% | 42.75B | |
+47.81% | 41.61B | |
+11.61% | 41.34B | |
-12.36% | 26.59B | |
+8.12% | 25.49B | |
-23.57% | 18.12B | |
+29.79% | 12.24B | |
-1.99% | 11.76B | |
+7.99% | 11B |